ATLASATLAS fair value
ATLAS has no fair value for this stock today.
SinoMab BioScience (3681.HK)
SinoMab BioScience share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
HK$1.02▼ -2.86%
Prices as of Oct 27, 2026 · HKD
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on SinoMab BioScience in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On SinoMab BioScience
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives SinoMab BioScience a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between HK$0.926 and HK$1.11; in 9 out of 10, between HK$0.788 and HK$1.31. Estimated annual volatility is 44%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- HK$1.5B
- Market cap (USD)
- $194M
- 52-week high
- HK$2.19
- 52-week low
- HK$0.960
- Revenue (12 months)
- CN¥5.7M
- Operating margin
- 0.0%
- Net margin
- 0.0%
- Beta
- 0.66
What this means
ATLAS does not publish a fair value for 3681.HK right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 3681.HK has traded between HK$0.960 and HK$2.19. Today it is 53.4% below that high and 6% above its low.
Its beta is 0.66: it tends to move less than the market.
About the company
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics in Mainland China and Hong Kong.
Want to see everything about SinoMab BioScience?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does SinoMab BioScience do?
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics in Mainland China and Hong Kong.
What is the chance 3681.HK goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, 3681.HK ends the month between HK$0.926 and HK$1.11.
How big is SinoMab BioScience and what is its P/E ratio?
SinoMab BioScience's market capitalization is HK$1.5B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is 3681.HK?
ATLAS estimates annual volatility at 44%. In a typical month, half of the outcomes end between HK$0.926 and HK$1.11.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer